ATLANTA, April 29, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the RBC 2025 Global Healthcare Conference in New York on May 20, 2025. Management will host 1x1 investor meetings as well as a fireside chat at 11:30 a.m. Eastern Time on the same day, May 20, 2025. Interested investors and other parties may also listen to a simultaneous webcast of the presentation by logging onto the Investor Relations section of the C ...

The U.S. stock markets have been rattled by the new tariff regime imposed by President Trump earlier this year. The President has been indicative of tariff hike on its trading partner since he assumed the Oval office. The S&P 500 Index made its all-time high in mid-February before starting its downtrend. The major fall across global markets started earlier this month when the U.S. government announced a blanket tariff of 10% for all imports and a higher rate for key trading partners on April 2. The highest ...

ATLANTA, April 22, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the Bank of America Securities 2025 Health Care Conference in Las Vegas on May 14, 2025. Management will host 1x1 investor meetings as well as a presentation at 3:15 p.m. Pacific Time on the same day, May 14, 2025. Interested investors and other parties may also listen to a simultaneous webcast of the presentation by logging onto the Investor Relations s ...

ATLANTA, April 17, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 8, 2025, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available three hours after the call and can be accessed by d ...

ATLANTA, April 03, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced that it has entered into an agreement to acquire Thrive Skilled Pediatric Care ("Thrive SPC"). The transaction is expected to close in the second fiscal quarter of 2025, subject to customary regulatory approvals. Thrive SPC is one of the largest independent providers of pediatric h ...

Core Viewpoint - Aveanna Healthcare (AVAH) has demonstrated significant stock performance and financial improvement, with a 45.1% surge in shares recently, indicating strong market confidence in the company's growth strategies and operational execution [1][3]. Financial Performance - In the fourth quarter of 2024, Aveanna reported revenues of $519.9 million, an 8.6% increase year-over-year, and a gross margin of $171.7 million, reflecting a 15.7% rise [2]. - The company achieved a net income of $29.2 million for the quarter, a notable recovery from a net loss of $25.7 million in the same quarter of 2023 [2]. Year-to-Date Performance - Year-to-date, AVAH shares have increased by 19.7%, outperforming the Zacks Medical-Outpatient and Home Healthcare sector's growth of 3.9% and the S&P 500 Index's decline of 4% [3][4]. Strategic Initiatives - Aveanna's focus on expanding preferred payor agreements has led to a significant increase from 14 to 22 agreements in its Private Duty Services (PDS) segment, now accounting for approximately 50% of total managed care organization volumes [11]. - The company successfully secured government reimbursement rate increases in 2024, achieving double-digit improvements in key states, which has enhanced caregiver hiring and revenue growth [12]. Long-Term Growth Prospects - Aveanna's long-term growth strategy includes diversification across PDS, Home Health & Hospice, and Medical Solutions, with a focus on high-value partnerships to improve margins and efficiency [18]. - The global home healthcare market is projected to grow at a CAGR of 7.96% from 2024 to 2030, positioning Aveanna to benefit from the increasing demand for home-based care solutions [19]. Valuation and Investment Opportunity - Aveanna is currently trading at a forward price-to-sales (P/S) multiple of 0.5X, significantly below the industry average of 2.73X, indicating a potential upside for value-focused investors [15]. - The company's sales growth is projected to be 4.1% in 2025 and 5.2% in 2026, with EPS growth expected to rise significantly, reaching 33.3% in 2025 and 75% in 2026 [22]. Challenges - A key challenge for Aveanna is the ongoing labor shortage in the healthcare sector, which affects the recruitment and retention of qualified caregivers and nurses [24]. - Wage pressures and competition for talent continue to pose challenges, despite the company's efforts to negotiate higher reimbursement rates to improve hiring trends [25].

Core Viewpoint - Aveanna Healthcare's stock has experienced a significant increase due to strong financial performance and positive investor sentiment, with a notable turnaround in net income and optimistic revenue projections for 2025 [2][4]. Company Performance - Aveanna Healthcare reported an 8.6% increase in quarterly revenue, achieving a net income of $29.2 million compared to a net loss in the previous year [2]. - The company is expected to post break-even quarterly earnings per share, reflecting a year-over-year change of +100%, with projected revenues of $498.92 million, up 4.2% from the year-ago quarter [3]. Future Outlook - Aveanna's projected revenue for 2025 is between $2.10 billion and $2.12 billion, indicating continued EBITDA improvement [2]. - The consensus EPS estimate for the upcoming quarter has remained unchanged over the last 30 days, suggesting that the stock's price movement may depend on future earnings estimate revisions [4]. Industry Context - Aveanna operates within the Zacks Medical - Outpatient and Home Healthcare industry, which includes other companies like Quest Diagnostics [4]. - Quest Diagnostics has a consensus EPS estimate of $2.20 for its upcoming report, reflecting a +7.8% change from the previous year [5].

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Aveanna Healthcare (AVAH) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.Aveanna Healthcare is a member of our Medical group, which includes 1012 different companie ...

Financial Data and Key Metrics Changes - Revenue for Q4 2024 was approximately $520 million, representing an 8.6% increase over the prior year period [8] - Full year 2024 revenue was approximately $2.024 billion, a 6.8% increase over the prior year [9] - Adjusted EBITDA for Q4 was $55.2 million, a 42.6% increase year-over-year, primarily due to improved payer rates and cost reduction efforts [8][9] - Full year 2024 adjusted EBITDA was $183.5 million, a 31.8% increase over the prior year [9] Business Line Data and Key Metrics Changes - Private Duty Services (PDS) revenue for Q4 was approximately $422.2 million, a 10.1% increase, driven by a volume increase of 4% [28][29] - Home Health and Hospice segment revenue for Q4 was approximately $54.4 million, a 0.6% increase, with 76% of admissions being episodic [33][35] - Medical Solutions segment revenue for Q4 was $43.3 million, a 4.8% increase, with revenue per unique patient served at approximately $486, up 5.9% [36] Market Data and Key Metrics Changes - Preferred payer agreements accounted for approximately 50% of total PDS Managed Care Organization (MCO) volumes, up from 47% in Q3 [16] - The company secured twelve private duty services state rate increases for the full year 2024, with significant improvements in Georgia and Massachusetts [13] Company Strategy and Development Direction - The company continues to execute its strategic transformation strategy focused on preferred payers and obtaining adequate rates from government partners [9][11] - Five primary strategic initiatives for 2025 include enhancing partnerships with government partners, identifying cost efficiencies, modernizing the medical solutions business, managing capital structure, and engaging employees [22][24] - The company anticipates a 2025 revenue range of $2.1 billion to $2.12 billion and an adjusted EBITDA range of $190 million [24] Management's Comments on Operating Environment and Future Outlook - Management noted that the demand for home and community-based care remains strong, with ongoing efforts to address labor market challenges [10][11] - The company is optimistic about returning to a normalized growth rate in its business segments, supported by improved caregiver hiring and retention trends [12] - Management expressed confidence in achieving their strategic goals and highlighted the importance of aligning clinical capacity with preferred payers [19][21] Other Important Information - The company had liquidity of approximately $260 million at the end of Q4, with cash on hand of approximately $84 million [40] - The company expects to see continued cash flow benefits as top-line growth and cost management initiatives come to fruition in 2025 [43] Q&A Session Summary Question: Guidance on top-line growth and EBITDA margins - Management characterized their guidance as prudent, expecting continued momentum in 2025 with significant transformation [50][52] Question: M&A pipeline and focus areas - The company is focused on tuck-in M&A in home health and private duty services, with plans to remain within their capital structure [56][58] Question: PDS segment rate growth and gross margin progression - Management indicated confidence in PDS growth rates, with expectations for a return to a $10 to $10.50 spread per hour [62][66] Question: Medical solutions payer strategy and contract conversions - The company is aligning clinical capacity with preferred payers to improve clinical outcomes and cash collections [78][80] Question: Medicaid regulatory changes and policy discussions - Management expressed optimism about being a cost saver for government programs and maintaining strong dialogue with regulatory counterparts [88][90] Question: Revenue guidance for PDS revenue growth - Management expects 3% to 5% total revenue growth in the PDS segment, with a focus on increasing preferred payer agreements [108][110]

Aveanna Healthcare Holdings Inc. AVAH reported on Thursday fourth-quarter adjusted EPS of five cents, a turnaround from a loss of two cents.Home care platform provider reported sales of $519.9 million, up 8.6% year-over-year, beating the consensus of $499.6 million.The overall revenue increase was attributable to a $38.7 million increase in Private Duty Services segment revenue, a $2 million increase in Medical Solutions segment revenue, and a $0.3 million increase in Home Health & Hospice segment revenue.C ...